News Column

Secant Medical Taps Dawn Porter Eringis as VP of Business Development and Marketing

February 28, 2014

Secant Medical has named Dawn Porter Eringis as Vice President, Business Development and Marketing.

In a release, the Company said that she was previously Vice President, Commercialization and Scientific Affairs at PolyMedix, Inc., a biotechnology company that she co-founded in 2002. In addition to overseeing the implementation of new business development and marketing programs, Eringis will manage strategic licensing opportunities and academic business partnerships for Secant Medical.

"Dawn's extensive industry knowledge will play a key role in ensuring that we maintain a forward momentum in our commitment to developing and commercializing advanced biomaterial technology platforms," said Jeff Robertson, president. "Her leadership will help us continue to build a strong R&D pipeline while also maintaining our focus on business partnerships with clients and academia."

Eringis has also held positions at Pfizer, Inc., Johnson & Johnson-Merck, Guilford Pharmaceuticals, Inc., the American Red Cross and Locus Pharmaceuticals, Inc.

Secant Medical provides advanced biomaterials and biomedical textile structures to the medical device industry.

((Comments on this story may be sent to

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Health & Beauty Close - Up

Story Tools